Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Novel Synthetic Adsorptive Depth Filter Media for CHO Harvest Clarification
John Amara, Ph.D. and Michael Dullen Merck, 80 Ashby Road, Bedford, MA, 01730, USA
Expanding Adoption of Single-Use Systems Drives Need for Wider Range of Sterile Connector Technologies
James Barry, Director of Marketing, Americas, Pall Biotech
Benefits of Mixed-Mode Cation Exchange Chromatography: CMM HyperCel™ Sorbent Used for Monoclonal Antibody and Other Recombinant Protein Purification
Continuous processing optimization with smarter tools
Barbara Paldus, Ph.D.
Vice President & General Manager Finesse, part of Thermo Fisher Scientific
Headline News
Nipocalimab Sjögren’s data highlight symptom improvements most valued by patients
Livdelzi improves ALP normalisation rates in Phase III PBC study
Zura Bio discontinues tibulizumab development in hidradenitis suppurativa after Phase II miss
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Manufacturing in the Industry 4.0 era: how to balance innovation with performance while not being disrupted
Presented by Christos Varsakelis, Senior Manager Global Analytics and Innovation, GlaxoSmithKline Biologicals SA, Mark Demesmaeker, Head of Data Analytics at Sartorius Stedim Biotech and Roger-Marc Nicoud, President & CEO Ypso-Facto
10th March 2021
An Interview with Dr Günter Jagschies, of GE BioProcess teams on What are the main opportunities and challenges in the rapidly evolving Asian biopharma markets?
Presented by An Interview with Dr. Günter Jagschies, business advisor for the GE BioProcess teams
18th June 2018
Hybrid Models: The Best of Both (Mechanistic & Empirical) Worlds to Accelerate and De-Risk Process Development
Presented by Christian Airiau, PhD, Global Head Data Sciences, Biologics Development at Sanofi and Chris McCready, Lead Data Scientist at Sartorius Stedim Biotech
16th March 2021
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
